Product Information
GLIMEPIRIDE 4 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.0518 per EA under NDC 16729000316. Its NADAC has been published 506 times since Sep 14, 2016.
FDA first approved this application on Aug 23, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Glimepiride market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
4 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729000316
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
GLIMEPIRIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078181FDA Approved
8/23/2007
TE Code
AB
On Market Since
8/23/2007
Pharmacological Classes
Price Statistics
The NADAC for GLIMEPIRIDE 4 MG TABLET has been published 506 times since Sep 14, 2016, and over the history we have for it it has declined 68.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0518 per EA |
|---|---|
| All-time high | $0.1700 (Oct 12, 2016) |
| All-time low | $0.0274 (May 22, 2024) |
| 52-week high | $0.0518 |
| 52-week low | $0.0375 |
| Median price | $0.0525 |
| Average price | $0.0621 |
| Largest weekly change | +73.8% (Jun 19, 2024) |
| Weeks tracked | 506 |
| Tracking since | Sep 14, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
+35.9%
1Y
+11.1%
3Y
+4.7%
5Y
+3.5%
All
-68.6%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 38% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GLIMEPIRIDE 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLIMEPIRIDE 4 MG TABLET, manufactured by Accord Healthcare Inc., is $0.0518 per EA (NDC 16729000316), effective May 20, 2026.
How has the price of GLIMEPIRIDE 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLIMEPIRIDE 4 MG TABLET has declined 68.6%. It has been tracked across 506 weekly CMS publications since Sep 14, 2016.
What are the highest and lowest recorded NADAC prices for GLIMEPIRIDE 4 MG TABLET?
Since Sep 14, 2016, the NADAC for GLIMEPIRIDE 4 MG TABLET has ranged from a low of $0.0274 (May 22, 2024) to a high of $0.1700 (Oct 12, 2016), with a median of $0.0525 per EA.
Are there cheaper alternatives to GLIMEPIRIDE 4 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLIMEPIRIDE 4 MG TABLET, is $0.0323 per EA — about 38% below GLIMEPIRIDE 4 MG TABLET.
Who manufactures GLIMEPIRIDE 4 MG TABLET?
GLIMEPIRIDE 4 MG TABLET (NDC 16729000316) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.